Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.1003500 on May 10, 2004

Published online before print May 10, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1003500v1
76/2/399    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, M.
Right arrow Articles by Tabel, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, M.
Right arrow Articles by Tabel, H.
(Journal of Leukocyte Biology. 2004;76:399-405.)
© 2004 by Society for Leukocyte Biology

Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells

Meiqing Shi, Guojian Wei, Wanling Pan and Henry Tabel1

Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

1Correspondence: Department of Veterinary Microbiology, WCVM, University of Saskatchewan, 52 Campus Drive, Saskatoon, Saskatchewan, S7N 5B4, Canada. E-mail: tabel{at}sask.usask.ca


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Immunohistochemical double-label technique was used to detect trypanosomal antigen in macrophages. Immunoglobulin (Ig)M as well as IgG2a monoclonal antibodies (mAb) specific for the variant surface glycoprotein (VSG) mediated phagocytosis of Trypanosoma congolense variant antigenic type (VAT) TC13 by macrophages [bone marrow-derived macrophage cell line from BALB/c (BALB.BM)] in vitro. Administration of these IgM or IgG2a antibodies to BALB/c mice 30 min after injection of 3 x 108 T. congolense mediated phagocytosis of trypanosomes by Kupffer cells of the liver within 1 h. Plasma levels of the monokines interleukin (IL)-1ß, IL-10, and IL-12p40 were significantly increased 6–48 h after phagocytosis. In BALB/c mice infected with 103 T. congolense, a small degree of phagocytosis of trypanosomes by Kupffer cells, mediated by actively synthesized antibodies, was detected as early as 5 days after infection. Phagocytosis of trypanosomes was dramatically enhanced on day 6. Concomitantly, the Kupffer cells trippled in size. In BALB/c mice infected for 6 days, treatment with IgM or IgG2a mAb specific for T. congolense VSG led to clearance of VAT TC13 parasitemia but did not prevent death at the second parasitemia of a different VAT. We conclude that IgM as well as IgG antibody mediate phagocytosis of trypanosomes by Kupffer cells.

Key Words: trypanosomes • liver • macrophages • immunity • cytokines • immunohistochemistry


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
African trypanosomes cause infections in humans and livestock. They are extracellular hemoprotozoa and survive in the bloodstream of the host by complex evasion mechanisms, including antigenic variation of the variant surface glycoprotein (VSG) [1 ], immunosuppression [2 ], and polyclonal B cell activation [3 ]. Trypanosoma congolense is the most important pathogen for livestock [4 ]. BALB/c mice are highly susceptible to T. congolense and Trypanosoma brucei infections, whereas C57BL/6 mice are relatively resistant, as measured by levels of parasitemia, immunosuppression, and survival time [4 5 6 ]. It is widely accepted that macrophages play a central role during trypanosomiasis [2 , 4 , 7 , 8 ]. Phagocytosis of T. brucei or T. congolense by macrophages in the presence of immune sera in vitro has been shown by several investigators using Giemsa stain or electron microscopy [9 10 11 12 ]. In mice experimentally infected with T. brucei, the parasites were found to be cleared from the circulation by VSG-specific antibody [13 ], and the liver was shown to be the primary organ of clearance [14 , 15 ]. Our previous results showed that great amounts of trypanosomal antigens accumulated in Kupffer cells in the liver of mice infected with T. congolense [16 ]. The phagocytosis of T. congolense by Kupffer cells was found to be closely associated with the development of a systemic inflammatory response syndrome (SIRS). The rapid development of SIRS in susceptible BALB/c mice leads to early mortality of these mice [16 ]. Resistance to T. congolense infections in mice was observed to be correlated with the production of particular antibodies to common trypanosomal antigens, i.e., antibodies of immunoglobulin (Ig)G2a and IgG3 isotype but not of IgM class [17 ].

The purpose of this study was to further investigate the effects of phagocytosis of T. congolense on Kupffer cells as well as the potential role of the IgM versus IgG class of antibodies specific for VSG. We used immunohistochemical double-label techniques to analyze the phagocytosis of T. congolense in vitro and in vivo. We found that IgM as well as IgG2a monoclonal antibodies (mAb) specific for the VSG mediated phagocytosis of T. congolense by macrophages [bone marrow-derived macrophage cell line from BALB/c (BALB.BM)] in vitro. It is more important that we provide direct evidence that phagocytosis of trypanosomes by Kupffer cells in vivo was mediated by passively administered IgM as well as IgG antibodies specific for the VSG. The concentrations of monokines, including interleukin (IL)-1ß, IL-10, and IL-12p40, were significantly increased in the plasma 6–48 h after phagocytosis. Phagocytosis of trypanosomes by Kupffer cells, mediated by actively synthesized antibodies, was first detected on day 5 and was dramatically enhanced on day 6 post-infection. In BALB/c mice infected for 6 days, treatment with IgM or IgG2a mAb specific for T. congolense VSG led to clearance of variant antigenic type (VAT) TC13 parasitemia but did not prevent death at the second parasitemia of a different VAT.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Mice
Female, 8- to 10-week-old BALB/c AnNCrlBR (BALB/c) and C57BL/6NCrlBR (C57BL/6) mice and 5- to 6-week-old female outbred Swiss white mice (CD1) were purchased from the Animal Resource Center of the University of Saskatchewan (Saskatoon, Canada). The mice were kept in polycarbonate cages on sawdust and allowed free access to food and water throughout the experiments, according to the recommendations of the Canadian Council of Animal Care.

Parasite
T. congolense, Trans Mara strain, VAT TC13, was used in this study. The origin of this parasite strain has been described previously [18 ]. Frozen stabilates of parasites were used for infecting CD1 mice immunosuppressed with cyclophosphamide, and passages were made every third day as described previously [18 ]. The parasites purified from the blood of infected CD1 mice by diethylaminoethyl-cellulose chromatography [19 ] were used for infecting BALB/c mice.

Antibodies
The rat hybridoma MCAP497 (specific for mouse macrophage antigen F4/80) was purchased from American Type Culture Collection (Manassas, VA). Biotin-conjugated goat anti-rat IgG was purchased from Cedarlane (Hornby, Ontario, Canada). Biotin-conjugated goat anti-rabbit IgG was purchased from Vector Laboratories (Burlingame, CA). Goat anti-rabbit IgG Alexa Fluor 546 and streptavidin Alexa Fluor 488 were purchased from Molecular Probes (Eugene, OR). Purified anti-mouse CD16/CD32 [Fc receptor for IgG III/II (Fc{gamma}III/IIR), clone 2.4G2] for blocking FcRs, recombinant mouse IL-1ß, IL-10, IL-12p40, and paired antibodies against mouse IL-1ß, IL-10, and IL-12p40 were purchased from PharMingen (San Diego, CA). We produced a polyclonal antiserum against T. congolense in rabbits [16 ]. The production of mAb 6C1 (IgM), 1D11 (IgG2a), and 2D8 (IgG3), specific for the VSG of VAT TC13, has been described [20 ].

Phagocytosis of trypanosomes in vitro and in vivo
To test phagocytosis of T. congolense in vitro, the retrovirus-immortalized BALB.BM cell lines of mice were used [21 ]. BALB.BM (2x105) cells were grown in 0.4 ml complete medium, Dulbecco’s modified Eagle’s medium (DMEM)-10 [DMEM medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 50 mM 2-mercaptoethanol, and 100 IU penicillin and streptomycin (Life Technologies, Grand Island, NY)]. Cultures were performed in the Laboratory-Tek chamber slide system with eight wells (Nalge Nunc International, Napperville, IL) overnight at 37°C in a 5% CO2 atmosphere. Phagocytosis of trypanosomes was performed in the presence of mAb 6C1 (IgM) or 1D11 (IgG2a) at a concentration of 5 µg/ml with a constant macrophage: trypanosome ratio of 1:10. To allow for phagocytosis of trypanosomes, the chambers were incubated at 37°C for 1 h. Then, the chambers were rinsed with phosphate-buffered saline (PBS), the plastic case removed, and the cells on the microscope slide stained with immunofluorescent antibodies. To investigate antibody-mediated phagocytosis in vivo, BALB/c mice were injected with 3 x 108 VAT TC13 intravenously (i.v.). Thirty minutes later, the mice were injected with 1 mg mAb 6C1 (IgM) or 1D11 (IgG2a) in 200 µl PBS i.v. or 200 µl PBS alone as control. The mice were killed 1 h after the injection of antibodies. Liver sections were made for immunohistochemical stainings. To investigate the dynamics of phagocytosis, mediated by actively synthesized antibodies in vivo, BALB/c mice were infected with 103 VAT TC13 intraperitoneally (i.p.) and killed on days 0–7 post-infection. Liver tissues were collected for immunohistochemical staining for trypanosomal antigens and Kupffer cells.

Immunohistochemistry
For immunofluorescent double-staining of phagocytosis in vitro, BALB.BM cells cultured with trypanosomes in chamber slides were rinsed with PBS. FcRs were blocked with purified anti-mouse CD16/CD32 (Fc{gamma}III/IIR) and 2% bovine serum albumin (BSA). Then, the slides were incubated with rat anti-mouse F4/80 mAb for 30 min. After three washes in PBS, the slides were incubated with biotin-conjugated goat anti-rat IgG. After three washes with PBS, the slides were incubated with streptavidin Alexa Fluor 488 (Molecular Probes) for 30 min, rinsed with PBS, and fixed with 5% formalin for 10–15 min. The slides were incubated with rabbit polyclonal antiserum against T. congolense in PBS containing 0.1% saponin for 30 min, rinsed with PBS, and followed by staining with goat anti-rabbit IgG Alexa Fluor 546 for 30 min. Saponin treatment is required for detecting intracellular antigens. As a control for demonstration of intracellular antigen, we also did immunofluorescent double-staining for macrophage antigens and trypanosomes on cells that had not been treated with saponin. Without the use of saponin, parasite antigen within the cytoplasma of BALB.BM cells was not detectable.

For immunoperoxidase staining of parasite antigen or Kupffer cells in liver sections, the liver tissues were deparaffinized in xylene and rehydrated through a graded series of ethanol. The tissues were incubated with proteinase K (EC 3.4.21.64, Sigma Chemical Co., St. Louis, MO; 20 µg/ml in 10 mM Tris/HCl, pH 7.4–8.0) for 30 min at 37°C. The tissues were rinsed and incubated with 3% H2O2 in methanol for 10 min, followed by blocking with 2% BSA in PBS. Then, the tissues were incubated with rabbit polyclonal antiserum against T. congolense for 30 min, rinsed in PBS, incubated with biotin goat anti-rabbit IgG, and followed by staining with horseradish peroxidase (HRP) streptavidin (Vector Laboratories). For staining of Kupffer cells, the tissues were incubated with culture supernatant fluids of rat hybridoma MCAP497 for 30 min, rinsed in PBS, incubated with biotin goat anti-rat IgG, rinsed in PBS, and followed by staining with HRP streptavidin. The tissues were rinsed and incubated with 3,3'-diaminobenzidine (substrate kit, Vector Laboratories) for color development. Finally, the sections were counterstained with hematoxylin, dehydrated, and covered with a coverslip. For immunofluorescent double-staining of the liver sections, the tissues were deparaffinized, treated with proteinase, and blocked with 3% H2O2 and 2% BSA as described above. The tissues were incubated with culture supernatant fluids of rat hybridoma MCAP497 for 30 min, rinsed in PBS, incubated with biotin goat anti-rat IgG, rinsed in PBS, and followed by staining with streptavidin Alexa Fluor 488. After three washes with PBS, the tissues were incubated with rabbit polyclonal antiserum against T. congolense for 30 min, rinsed in PBS, and incubated with goat anti-rabbit IgG Alexa Fluor 546 for 30 min.

Cytokine assays
Groups of four BALB/c mice were injected i.v. with 3 x 108 VAT TC13, followed by injection of 1 mg mAb 6C1 (IgM) or mAb 1D11 (IgG2a) in 200 µl PBS or 200 µl PBS alone 30 min later. The mice were killed 6, 24, or 48 h after injection of antibodies or PBS. Plasma samples were collected from mice and stored at –20°C for cytokine measurement. Plasma samples were also collected from BALB/c mice 5 and 6 days after infection with 103 VAT TC13. The levels of IL-1ß, IL-10, IL-12p40, or interferon-{gamma} (IFN-{gamma}) in plasma were determined by routine sandwich enzyme-linked immunosorbent assay (ELISA) using Immulon-4 plates (Dynax Technologies Inc., Chantilly, VA), according to the manufacturer’s suggested protocols (PharMingen). Each sample of plasma was tested for each cytokine in triplicate.

Measurement of sizes of Kupffer cells
Images of liver sections were taken by a digital camera, saved in the computer, and analyzed by a software of Northern Eclipse, version 6.0 (Empix Imaging Inc., Mississauga, Ontario, Canada). Each group included four individual animals, and one image was taken from each individual animal. The size of each image was chosen to be 90,500 square µ. The sizes of Kupffer cells were measured by using software of Northern Eclipse.

Estimation of parasitemia and determination of antigenic variant type and survival time
A drop of blood was taken from the tail vein of each infected mouse. The parasitemia was estimated by counting the number of parasites present in at least 10 fields at x400 magnification by phase-contrast microscopy. The presence or absence of VAT TC13 was determined by a motility test using mAb 2D8 as described previously [20 ]. Briefly, 2 µl mAb 2D8 was mixed with 20 µl infected blood and incubated on ice for 10 min. All VAT TC13 trypanosomes become completely immobile within minutes, and only T. congolense of a VAT other than TC13 will remain motile. This is a rapid and convenient method to test for the presence of VAT TC13.

The survival time was defined as the mean number of days post-infection that the infected mice remained alive.

Statistical analysis
Data are represented as means ± SE. Significance of differences was determined by Student’s t-test or ANOVA using StatView SE 1988 software (Abacus Concepts, Berkeley, CA).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
IgM or IgG2a antibody-mediated phagocytosis of trypanosomes by macrophages in vitro
BALB.BM cells were incubated with T. congolense in the presence of monoclonal IgM (6C1) or IgG2a (1D11) specific for VSG of VAT TC13 or in the absence of antibody for 60 min. Immunofluorescent double-staining for macrophages and trypanosomes was performed to detect phagocytosis of trypanosomes by BALB.BM cells. No parasite antigen was observed in BALB.BM cells when specific antibody was absent, although some parasites were seen to be adhered to the BALB.BM cells (Fig. 1A ). In contrast, trypanosomal antigens were detected in BALB.BM cells (Fig. 1B and 1C) when specific IgM or IgG2a mAb was added, indicating that IgM and IgG2a antibody classes could mediate phagocytosis of trypanosomes in vitro. After having been phagocytosed, the trypanosomes lost their characteristic shape. The trypanosomal antigens within macrophages were visible as round bodies, indicating that they were located within phagosomes (Fig. 1B and 1C) .



View larger version (101K):
[in this window]
[in a new window]
 
Figure 1. Phagocytosis of T. congolense mediated by IgM or IgG2a mAb specific for VSG in vitro and in vivo. Phagocytosis of T. congolense by BALB.BM cells in vitro (A–C): no phagocytosis of T. congolense (red, arrows) in the absence of mAb (A); phagocytosis of T. congolense (red) by BALB.BM cells (green) in the presence of mAb 6C1 (IgM; B) or 1D11 (IgG2a; C) at concentration of 5 µg/ml. Phagocytosis of T. congolense in vivo by Kupffer cells of the liver (D–I): BALB/c mice were infected i.v. with 3 x 108 trypanosomes and injected with 0.2 ml PBS only (D, G) or 1 mg mAb 6C1 (IgM; E, H) or mAb 1D11 (IgG2a; F, I) in 0.2 ml PBS 30 min later. The infected mice were killed 1 h after injection of antibodies or PBS (see text). Peroxidase staining showed little parasite antigen (arrows) in the liver when no mAb was given (D). In contrast, a lot of trypanosomal antigens accumulated in the liver when mAb 6C1 (IgM; E) or mAb 1d11 (IgG; F) was administered. Immunofluorescent double-staining showed trypanosomes (red, arrows) outside of Kupffer cells (green) when no mAb was given (G). Trypanosomal antigens (red) were observed in Kupffer cells (green) after administration of mAb 6C1 (IgM; H) or mAb 1D11 (IgG2a; I). (A–I) Original maginification, x400; for insets, x1000.

 
IgM or IgG2a antibody-mediated phagocytosis of T. congolense by Kupffer cells in vivo
Our previous results indicated that trypanosomal antigens were located in Kupffer cells in infected mice [16 ]. Thus, we examined whether the phagocytosis of trypanosomal antigens by Kupffer cells was mediated by trypanosome-specific antibodies. BALB/c mice were infected i.v. with 3 x 108 T. congolense. Thirty minutes later, the mice were injected i.v. with 1 mg IgM or IgG2a mAb specific for VSG of T. congolense VAT TC13 or PBS only. Considerable numbers of parasites (41±5 parasites per field) were detected in the blood of mice immediately after injection of T. congolense. Parasitemia of infected mice dropped to undetectable levels within 10 min after injection of IgM or IgG2a mAb. Parasitemia, however, did not decline in the blood of mice injected with PBS alone (data not shown). Immunoperoxidase staining showed that only few parasite antigens were observed in liver sections of infected mice treated with PBS alone. In these mice, the parasites seemed to be outside of cells (Fig. 1D) . In contrast, great amounts of parasite antigen accumulated in some cells of the liver of the infected mice 60 min after injection of IgM or IgG2a (Fig. 1E and 1F) . To confirm that the parasite antigen-containing cells were Kupffer cells, immunofluorescent double-staining was performed. In the absence of antibodies, few parasites were detected in the liver of infected mice. They all were located outside of Kupffer cells (Fig. 1G) . As shown in Figure 1H and 1I , parasite antigens were located in Kupffer cells in the mice injected with IgM or IgG2a mAb.

Significant differences were also observed in the size of Kupffer cells after phagocytosis in vivo mediated by IgM or IgG2a compared with controls. However, there was no significant difference in the size of BALB.BM cells or Kupffer cells between IgM- or IgG2a-mediated phagocytosis (data not shown).

Dynamics of phagocytosis of trypanosomes by Kupffer cells of mice infected with T. congolense
To detect the dynamics of phagocytosis of parasites by Kupffer cells during infection, BALB/c mice were infected i.p. with 103 T. congolense VAT TC13. The infected mice were killed on days 0–7 post-infection. Immunoperoxidase staining showed that parasite antigens were undetectable in liver tissues from days 0 to 4 post-infection (Fig. 2A ). Parasite antigen was first detected in few Kupffer cells on day 5 post-infection (Fig. 2B) . Markedly increased accumulation of parasite antigens in Kupffer cells was observed on day 6 post-infection (Fig. 2C) .



View larger version (127K):
[in this window]
[in a new window]
 
Figure 2. Accumulation of trypanosomal antigens in Kupffer cells of the liver. BALB/c mice were infected with 103 T. congolense VAT TC13 i.p. Mice were killed on days 0–7 post-infection (see text). Peroxidase stain for trypanosomes (A–C): No trypanosomal antigen was detected on day 0 post-infection (A). The earliest time of detection of trypanosomal antigens was on day 5 (B). Accumulations of parasite antigens significantly increased on day 6 (C). Peroxidase stain (anti-F4/80) for Kupffer cells (D–F): Kupffer cells appeared not visibly enlarged up to day 5 (D, E). In contrast, Kupffer cells were markedly enlarged on day 6 (F). Original maginification, x400.

 
There was no visible difference in the size of Kupffer cells of infected mice killed on days 0–5 (Fig. 2D and 2E) . However, the Kupffer cells of infected mice were markedly enlarged, about threefold, on day 6 post-infection (Fig. 2F ; quantitative data not shown), which indicated that the Kupffer cells were strongly activated. We also measured the plasma levels of IFN-{gamma} in infected BALB/c mice. We found that the levels of IFN-{gamma} in the plasma were enhanced three- to fourfold from day 5 (88.9±5.0 pg/ml) to day 6 (407.3±59.9 pg/ml). Thus, the dramatic increase of sizes of Kupffer cells from day 5 to day 6 correlated with analogous increases of IFN-{gamma} levels in the plasma.

Plasma levels of monokines were significantly increased after phagocytosis of trypanosomes
We were wondering whether cytokines were secreted after phagocytosis of parasites. For this reason, we measured the plasma levels of some monokines such as IL-1ß, IL-10, and IL-12p40. BALB/c mice were infected with 3 x 108 T. congolense i.v. They were injected with 1 mg IgM or IgG2a mAb or PBS 30 min later. IL-1ß was undetectable in the plasma of all mice at 24 or 48 h post-injection of antibodies or PBS. We then measured the plasma levels of IL-1ß at 6 h post-injection of mAb or PBS alone, as it had been reported that secretion of IL-1ß by murine macrophages in vitro started 6 h after exposure of the macrophages to VSG of T. brucei rhodesiense [22 ]. When compared with uninfected mice, we did detect a significant increase of IL-1ß in the plasma of infected mice treated with IgM (P<0.01) or IgG (P<0.05) at 6 h post-injection of mAb (Fig. 3A ). Plasma levels of IL-10 of mice treated with IgM (P<0.05 for 24 h; P<0.01 for 48 h) or IgG2a (P<0.01 for 24 and 48 h) significantly increased at 24 and 48 h post-injection of the mAb compared with normal, uninfected mice (Fig. 3B) . IL-12p40 levels of mice treated with IgM (P<0.01) or IgG2a (P<0.01) mAb were also significantly enhanced at 48 h post-injection of the mAb, although there was no significant difference between mAb-treated mice and uninfected controls at 24 h post-infection (Fig. 3C) .



View larger version (26K):
[in this window]
[in a new window]
 
Figure 3. Cytokine release after IgM- or IgG2a-mediated phagocytosis of T. congolense in vivo. Groups of four BALB/c mice were infected i.v. with 3 x 108 VAT TC13. The infected mice were injected with 1 mg mAb 6C1 (IgM), mAb 1D11 (IgG2a) in 0.2 ml PBS, or 0.2 ml PBS alone 30 min later. Plasma samples were collected at 6 h (A) and 24 h and 48 h (A–C) post-infection. Concentrations of IL-1ß, IL-10, and IL-12p40 were measured by ELISA as described in Materials and Methods. Data are presented as means ± SE. The results presented are representative of two experiments.

 
It is interesting that infected mice, which did not receive antibodies, also produced more cytokines than uninfected controls: significantly more IL-1ß (P<0.05; Fig. 2A ) at 6 h and IL-10 (P<0.01; Fig. 2B ) and IL-12p40 (P<0.01; Fig. 2C ) at 24 or 48 h after injection of PBS.

Treatment of the infected mice with IgM or IgG2a mAb specific for VAT TC13 led to clearance of TC13 parasitemia and increased survival but did not prevent death associated with the parasitemia of a different VAT
Finally, we treated mice, which had been infected with 103 T. congolense, with IgM or IgG2a mAb specific for VSG of VAT TC13 on day 6 post-infection. At this time, the mice had a parasitemia of 5 x 107 trypanosomes/ml blood. Initially, we treated the infected mice with 1 mg IgM or IgG2a mAb, as 1 mg mAb was enough to clear 3 x 108 TC13 when given 30 min after infection (see above). However, parasites could still be detected in the blood after injection of 1 mg mAb (data not shown). Then, another group of infected mice was injected with a total of 4 mg mAb. As shown in Figure 4 , the parasitemia was cleared on days 7 and 8 after treatment with IgM or IgG2a mAb on day 6. There was no significant difference between the second parasitemias of mice treated with 4 mg IgM or IgG2a mAb (Fig. 4) . The untreated mice infected with T. congolense succumbed to their infections within 9–11 days with high parasitemia (Figs. 4 and 5 ), of which 99% were of VAT TC13 (Fig. 4) . In contrast, 50% of the infected mice treated with mAb survived for more than 17 days after infection (Fig. 5) . The second parasitemias of the antibody-treated mice were 100% of a VAT (VAT TCx) different from VAT TC13. The survival of infected mice treated with IgM (P<0.01) or IgG2a (P<0.05) mAb was significantly increased as compared with untreated controls (Fig. 5) . However, there was no significant difference in survival between IgM- and IgG2a-treated mice (Fig. 5) .



View larger version (16K):
[in this window]
[in a new window]
 
Figure 4. Administration of mAb 6C1 (IgM) or mAb 1D11 (IgG2a) leads to clearance of VAT TC13 parasitemia but does not prevent death of T. congolense-infected mice at the second parasitemic wave of a different VAT (TCx). Groups of four BALB/c mice were infected i.p. with 103 VAT TC13. The infected mice were injected with 4 mg mAb 6C1, mAb 1D11 in 0.4 ml PBS, or 0.4 ml PBS only on day 6 post-infection (arrow). Mice were monitored daily for parasitemia (A). The numbers of VAT TC13 and VAT TCx were determined in the infected mice, which did not receive mAb (B). Differentiation of VAT TC13 from VAT TCx was achieved by a motility test using mAb 2D8 as described previously [20 ]. The results presented are representative of three experiments.

 


View larger version (17K):
[in this window]
[in a new window]
 
Figure 5. Survival of BALB/c mice infected with T. congolense VAT TC13 was significantly enhanced by administration of mAb 6C1 (IgM) or mAb 1D11 (IgG2a). Groups of four BALB/c mice were infected i.p. with 103 VAT TC13. The infected mice were injected with 4 mg mAb 1D11, mAb 6C1 in 0.4 ml PBS, or 0.4 ml PBS on day 6 post-infection. Mice were monitored daily for survival. The results presented are representative of three experiments.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Different research groups, using Giemsa stain or electron microscopy technique, have shown phagocytosis of trypanosomes by macrophages in vitro [10 11 12 , 23 24 25 ]. In this study, we developed immunofluorescent double-staining to examine the phagocytosis. We investigated whether there was an apparent difference in phagocytosis mediated by IgM or IgG2a antibodies. We showed that phagocytosis of trypanosomes by BALB.BM cells occurred in the presence of IgG2a or IgM mAb specific for VSG in vitro. In contrast, no phagocytosis was observed in the absence of specific antibodies. In agreement with our previous in vitro findings, using Giemsa staining [12 ], the results reported here suggest that not only IgG2a but also IgM mAb can mediate phagocytosis of trypanosomes by macrophages in vitro.

Our previous results demonstrated that tremendous amounts of trypanosomal antigens were located in Kupffer cells of susceptible BALB/c mice infected with T. congolense [16 ]. However, the mechanism of phagocytosis remains to be determined. In this study, we found that significant amounts of parasite antigen accumulated in some cells of the liver of BALB/c mice, which were infected with 3 x 108 T. congolense VAT TC13 and 30 min later, received IgG2a or IgM mAb specific for VSG of VAT TC13. No phagocytosed antigen was found in infected mice, which received PBS only. Immunofluorescent double-staining further demonstrated that the antigen-containing cells were Kupffer cells (Fig. 1H and 1I) . The accumulation of trypanosomal antigen in Kupffer cells was associated with failure to detect parasitemia. Thus, we have provided the first direct evidence that IgG2a as well as IgM anti-VSG antibodies mediated phagocytosis of trypanosomes by Kupffer cells in vivo. Macrophages have Fc{gamma}Rs. It is possible that phagocytosis of trypanosomes mediated by IgG2a mAb is dependent on Fc{gamma}Rs [26 ]. The mechanisms of phagocytosis of African trypanosomes, mediated by IgM anti-VSG, are presently unknown. Although a FcR (Fc{alpha}/µR) for IgM has been described to be expressed on macrophages [27 ], the biological significance of this Fc{alpha}/µR has still to be defined. It has been shown that IgM antibodies specific for VAT TC13 activated complement and deposited murine C3b onto T. congolense [28 ]. We recently found that complement receptor CR3 is one of the receptors involved in IgM antibody-mediated phagocytosis of T. congolense by peritoneal macrophages (Pan et al., unpublished).

One of the outcomes of phagocytosis was up-regulation of production of monokines such as IL-1ß, IL-10, and IL-12p40 in our model. IL-1ß was secreted within the first several hours post-infection. This finding is in the line with previous data from in vitro studies [22 ]. We have no direct evidence to indicate that Kupffer cells secreted these cytokines. However, it is unlikely that antigen-specific lymphocytes secreted the cytokines within 6–48 h after infection. We suggest that splenic macrophages and/or Kupffer cells contributed to the enhanced synthesis of these cytokines. It is interesting that monokine levels in plasma of T. congolense-infected mice were enhanced even without injection of antibodies. In other words, monokines were secreted even without apparent phagocytosis of parasites, as we found that parasites were located outside of Kupffer cells in the absence of antibodies (Fig. 1D and 1G) . One possible explanation for this observation is that the preparation of 3 x 108-purified parasites used for inoculation might have contained a certain number of damaged or dead trypanosomes, which were phagocytosed and were sufficient to induce cytokine production in macrophages. The detection of their phagocytosis might have been below the sensitivity of the immunohistochemistry technique. In addition, it has been found that African trypanosomes shed VSG into the plasma of infected mice [29 30 31 ]. Soluble VSG (sVSG) can bind to and stimulate macrophages to synthesize cytokines [22 , 31 32 33 ]. It is surprising that infected mice treated with PBS produced significantly more IL-12p40, particularly at 48 h (Fig. 3C) . At this time, the PBS-treated mice had a very high parasitemia, ~109/ml. The continual shedding of VSG from such a high parasitemia might have yielded great amounts of sVSG, which in turn, might have stimulated Kupffer cells and splenic macrophages to produce the high levels of IL-12p40. In fact, the story might be even more complex. The process of antibody-mediated phagocytosis of trypanosomes, although eliciting macrophages to produce more IL-12p40 than being produced by resting macrophages (Fig. 3C) , might for yet unknown reasons, elicit a weaker signal for inducing synthesis of IL-12p40 than the binding of sVSG to macrophages by itself.

Phagocytosis of trypanosomes by Kupffer cells in BALB/c mice infected with 103 VAT TC13 could first be detected on day 5 (Fig. 2B) . A dramatic increase of phagocytosis occurred on day 6 post-infection (Fig. 2C) . In correlation, the Kupffer cells were significantly enlarged on day 6 post-infection, indicating a high state of activation of Kupffer cells (Fig. 2F) . The dynamics of phagocytosis and Kupffer cell activation was correlated with at least three parameters: rising parasitemia (Fig. 2) , increasing plasma levels of detectable IgM anti-VSG [17 ], and marked increases of plasma levels of IFN-{gamma} from day 5 to day 6 (see Results; ref. [34 ]). There is a puzzling, still unanswered question: Why do the susceptible BALB/c mice fail to control the parasitemia in spite of demonstrable IgM anti-VSG antibodies appearing earlier in infected BALB/c than in infected C57BL/6 mice [17 ] and the presence of the highly activated Kupffer cells (Fig. 2C and 2F) ?

With the use of radioactive techniques, antibody-mediated clearance of 75Se-labeled trypanosomes in mice infected with T. brucei has been reported [14 , 15 ]. The majority of labeled parasites was concentrated in the liver. Less were present in spleen and blood [14 , 15 ]. In this study, we first infected BALB/c mice with 103 T. congolense and then treated the infected mice with IgG2a or IgM mAb specific for TC13 VSG on day 6 post-infection. IgG2a or IgM mAb (1 mg) was not sufficient to clear the parasitemia of 5 x 107 parasites/ml in BALB/c mice infected for 6 days. However, 1 mg mAb cleared the parasitemia of ~108 parasites/ml, when the mAb were injected 30 min after infection. What made the difference? During the 6 days of infection, the parasites presumably shed a lot of sVSG [29 , 31 ]. This process might interfere with phagocytosis of trypanosomes at two levels. First, the shed sVSG might bind a lot of anti-VSG antibody and thus is not available for the whole trypanosome. Second, free sVSG and/or complexes of the sVSG/anti-VSG antibodies might be phagocytosed by the Kupffer cells and thus mediate internalization of crucial receptors, which are not available at optimal numbers for the whole trypanosomes.

The parasitemia of infected mice was cleared by administration of the large amounts of 4 mg mAb (Fig. 4A) . The survival of infected mice treated with the mAb significantly increased as compared with untreated control. However, the treatments did not prevent death associated with a second parasitemia of a variant other than TC13. There was no significant difference between the effects of treatments with IgG2a or IgM mAb regarding parasitemia (Fig. 4A) and survival time (Fig. 5) of infected mice. This seems to suggest that IgG2a and IgM, in terms of protein concentrations, are equally efficient in mediating phagocytosis.

In summary, our results clearly indicated that IgM and IgG2a mAb specific for VSG could mediate phagocytosis of trypanosomes by macrophages in vitro and by Kupffer cells in vivo, and phagocytosis of trypanosomes was associated with profound changes of Kupffer cells.


    ACKNOWLEDGEMENTS
 
This work was supported by a research grant from the Canadian Institutes of Health Research (to H. T.) and a postdoctoral fellowship from the Health Services Utilization and Research Commission of Saskatchewan (to M. S.). We thank Ian Shirley, Department of Veterinary Pathology, for his assistance in the quantitative analysis of macrophages sizes.

Received October 22, 2003; revised February 9, 2004; accepted April 13, 2004.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Cross, G. A. (1990) Cellular and genetic aspects of antigenic variation in trypanosomes Annu. Rev. Immunol. 8,83-110[CrossRef][Medline]
  2. Sileghem, M., Flynn, N. J., Darji, A., De Baetselier, P., Naessens, J. (1994) African trypanosomiasis Kierszenbaum, F. eds. Parasite Infections and the Immune System ,1-54 Academic New York, NY.
  3. Oka, M., Ito, Y. (1987) Polyclonal B-cell-activating factors produced by spleen cells of mice stimulated with a cell homogenate of Trypanosoma gambiense Infect. Immun. 55,3162-3167[Abstract/Free Full Text]
  4. Tabel, H., Kaushik, R. S., Uzonna, J. E. (2000) Susceptibility and resistance to Trypanosoma congolense infections Microbes Infect. 2,1619-1629[CrossRef][Medline]
  5. Greenblatt, H. C., Diggs, C. L., Rosenstreich, D. L. (1984) Trypanosoma rhodesiense: analysis of the genetic control of resistance among mice Infect. Immun. 44,107-111[Abstract/Free Full Text]
  6. Ogunremi, O., Tabel, H. (1995) Genetics of resistance to Trypanosoma congolense in inbred mice: efficiency of apparent clearance of parasites correlates with long-term survival J. Parasitol. 81,876-881[CrossRef][Medline]
  7. Askonas, B. A. (1985) Macrophages as mediators of immunosuppression in murine African trypanosomiasis Curr. Top. Microbiol. Immunol. 117,119-127[Medline]
  8. Noel, W., Hassanzadeh, G., Raes, G., Namangala, B., Daems, I., Brys, L., Brombacher, F., Baetselier, P. D., Beschin, A. (2002) Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice Infect. Immun. 70,6180-6187[Abstract/Free Full Text]
  9. Takayanagi, T., Nakatke, Y., Enriquez, G. L. (1974) Tyrpanosoma gambiense: phagocytosis in vitro Exp. Parasitol. 36,106-113[CrossRef][Medline]
  10. Mosser, D. M., Roberts, J. F. (1982) Trypanosoma brucei: recognition in vitro of two developmental forms by murine macrophages Exp. Parasitol. 54,310-316[CrossRef][Medline]
  11. Shakibaei, M., Frevert, U. (1992) Cell surface interactions between Trypanosoma congolense and macrophages during phagocytosis in vitro J. Protozool. 39,224-235[Medline]
  12. Kaushik, R. S., Uzonna, J. E., Radzioch, D., Gordon, J. R., Tabel, H. (1999) Innate resistance to experimental Trypanosoma congolense infection: differences in IL-10 synthesis by macrophage cell lines from resistant and susceptible inbred mice Parasite Immunol. 21,119-131[CrossRef][Medline]
  13. Crowe, J. S., Lamont, A. G., Barry, J. D., Vickerman, K. (1984) Cytotoxicity of monoclonal antibodies to Trypanosoma brucei Trans. R. Soc. Trop. Med. Hyg. 78,508-513[CrossRef][Medline]
  14. Macaskill, J. A., Holmes, P. H., Whitelaw, D. D., McConnell, I., Jennings, F. W., Urquhart, G. M. (1980) Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. II. Mechanisms in immune animals Immunology 40,629-635[Medline]
  15. Dempsey, W. L., Mansfield, J. M. (1983) Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity J. Immunol. 130,405-411[Abstract]
  16. Shi, M., Pan, W., Tabel, H. (2003) Experimental African trypanosomiasis: IFN-{gamma} mediates early mortality Eur. J. Immunol. 33,108-118[CrossRef][Medline]
  17. Uzonna, J. E., Kaushik, R. S., Gordon, J. R., Tabel, H. (1999) Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance Parasite Immunol. 21,57-71[CrossRef][Medline]
  18. Tabel, H. (1982) Activation of the alternative pathway of bovine complement by Trypanosoma congolense Parasite Immunol. 4,329-335[Medline]
  19. Lanham, S. M., Godfrey, D. G. (1970) Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose Exp. Parasitol. 28,521-534[CrossRef][Medline]
  20. Wei, G., Qualtiere, L., Tabel, H. (1990) Trypanosoma congolense: complement independent immobilization by a monoclonal antibody Exp. Parasitol. 70,483-485[CrossRef][Medline]
  21. Cox, G. W., Mathieson, B. J., Gandino, L., Blasi, E., Radzioch, D., Varesio, L. (1989) Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver J. Natl. Cancer Inst. 81,1492-1496[Abstract/Free Full Text]
  22. Mathias, S., Perez, R., Diffley, P. (1990) The kinetics of gene expression and maturation of IL-1 {alpha} after induction with the surface coat of Trypanosoma brucei rhodesiense or lipopolysaccharide J. Immunol. 145,3450-3455[Abstract]
  23. Takayanagi, T., Nakatake, Y., Enriquez, G. L. (1974) Attachment and ingestion of Trypanosoma gambiense to the rat macrophage by specific antiserum J. Parasitol. 60,336-339[CrossRef][Medline]
  24. Abolarin, M. O., Ormerod, W. E., Rowles, P. M. (1983) Phagocytosis of Trypanosoma brucei rhodesiense by peritoneal macrophages: a study by scanning electronmicroscopy J. Med. Microbiol. 16,157-164[Abstract]
  25. Ngaira, J. M., Nantulya, V. M., Musoke, A. J., Hirumi, K. (1983) Phagocytosis of antibody-sensitized Trypanosoma brucei in vitro by bovine peripheral blood monocytes Immunology 49,393-400[Medline]
  26. Aderem, A., Underhill, D. M. (1999) Mechanisms of phagocytosis in macrophages Annu. Rev. Immunol. 17,593-623[CrossRef][Medline]
  27. Shibuya, A., Sakamoto, N., Shimizu, Y., Shibuya, K., Osawa, M., Hiroyama, T., Eyre, H. J., Sutherland, G. R., Endo, Y., Fujita, T., Miyabayashi, T., Sakano, S., Tsuji, T., Nakayama, E., Phillips, J. H., Lanier, L. L., Nakauchi, H. (2000) Fc {alpha}/µ receptor mediates endocytosis of IgM-coated microbes Nat. Immunol. 1,441-446[CrossRef][Medline]
  28. Ogunremi, O. (1993) Genetics of Resistance to Trypanosoma congolense infection ,83-84 University of Saskatchewan Saskatoon, Canada. Ph.D. thesis
  29. Diffley, P., Strickler, J. E., Patton, C. L., Waksman, B. H. (1980) Detection and quantification of variant specific antigen in the plasma of rats and mice infected with Trypanosoma brucei brucei J. Parasitol. 66,185-191[CrossRef][Medline]
  30. Weitz, B. (1960) A soluble protective antigen of Trypanosoma brucei Nature 185,788-789
  31. Paulnock, D. M., Coller, S. P. (2001) Analysis of macrophage activation in African trypanosomiasis J. Leukoc. Biol. 69,685-690[Abstract/Free Full Text]
  32. Magez, S., Stijlemans, B., Radwanska, M., Pays, E., Ferguson, M. A., De Baetselier, P. (1998) The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors J. Immunol. 160,1949-1956[Abstract/Free Full Text]
  33. Coller, S. P., Mansfield, J. M., Paulnock, D. M. (2003) Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-{gamma}-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis J. Immunol. 171,1466-1472[Abstract/Free Full Text]
  34. Uzonna, J. E., Kaushik, R. S., Gordon, J. R., Tabel, H. (1998) Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-{gamma} antibodies alters trypanosome-susceptible mice to a resistant-like phenotype J. Immunol. 161,5507-5515[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Guilliams, G. Oldenhove, W. Noel, M. Herin, L. Brys, P. Loi, V. Flamand, M. Moser, P. De Baetselier, and A. Beschin
African Trypanosomiasis: Naturally Occurring Regulatory T Cells Favor Trypanotolerance by Limiting Pathology Associated with Sustained Type 1 Inflammation
J. Immunol., September 1, 2007; 179(5): 2748 - 2757.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. Caljon, J. Van Den Abbeele, B. Stijlemans, M. Coosemans, P. De Baetselier, and S. Magez
Tsetse Fly Saliva Accelerates the Onset of Trypanosoma brucei Infection in a Mouse Model Associated with a Reduced Host Inflammatory Response
Infect. Immun., November 1, 2006; 74(11): 6324 - 6330.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Shi, G. Wei, W. Pan, and H. Tabel
Experimental African Trypanosomiasis: A Subset of Pathogenic, IFN-{gamma}-Producing, MHC Class II-Restricted CD4+ T Cells Mediates Early Mortality in Highly Susceptible Mice
J. Immunol., February 1, 2006; 176(3): 1724 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Shi, G. Wei, W. Pan, and H. Tabel
Impaired Kupffer Cells in Highly Susceptible Mice Infected with Trypanosoma congolense
Infect. Immun., December 1, 2005; 73(12): 8393 - 8396.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1003500v1
76/2/399    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, M.
Right arrow Articles by Tabel, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, M.
Right arrow Articles by Tabel, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS